TxCell Granted US Orphan Drug Designation for Col-Treg in the Treatment of Chronic Non-Infectious Uveitis
A first-in-man clinical study is planned to start in 2016, with top line results expected end 2017
A first-in-man clinical study is planned to start in 2016, with top line results expected end 2017
Professor Paul Cockwell addresses the delegation at the 7th International Binding Site Symposium
ImmunoXpert™ blood test uses novel technology to accurately distinguish between bacterial and viral infections
Early identification of the disease will allow specific and extremely effective therapies for the treatment of patients
System from Quest Diagnostics' products business is first FDA-cleared Herpes Simplex Virus 1 and 2 test that uses genital swab or cerebrospinal fluid (CSF) specimen collection
Reprogramming microbes for innovative therapies
Unique System Proven to Improve Laboratory Workflow and Productivity for Infectious Disease
The CEO of EKF Molecular discusses the use of PointMan technology in recent clinical studies
Collaboration aims to develop novel antibody-based therapies targeting tumor-associated peptides derived from intracellular proteins
AMSBIO has introduced an expanded range of Adeno-associated virus (AAV) cloning and packaging services
Partnership seeks to advance scientific discovery by offering important bioreagents
Educational workshops, new diagnostics platforms address critical factors for lab success
Read on to discover the top analyzers for Clinical Chemistry